Commentary: Caution needed in introducing warfarin treatment

BMJ. 1995 Aug 26;311(7004):560-1. doi: 10.1136/bmj.311.7004.560.
No abstract available

Publication types

  • Comment

MeSH terms

  • Atrial Fibrillation / drug therapy
  • Cerebrovascular Disorders / prevention & control
  • Clinical Trials as Topic
  • Hemorrhage / chemically induced*
  • Humans
  • Warfarin / adverse effects*

Substances

  • Warfarin